[HTML] mdpi.com

[HTML][HTML] Beyond dopamine receptor antagonism: new targets for schizophrenia treatment and prevention

FV Gomes, AA Grace - International journal of molecular sciences, 2021 - mdpi.com
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat
psychosis, with all of the currently available antipsychotics acting through the antagonism of …
被引用次数：44 相关文章
[HTML] nih.gov

[HTML][HTML] Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

FV Gomes, AA Grace - International Journal of Molecular Sciences, 2021 - ncbi.nlm.nih.gov
Abstract Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic
drugs to treat psychosis, with all of the currently available antipsychotics acting through the …
[PDF] usp.br

[PDF][PDF] Beyond dopamine receptor antagonism: New targets for Schizophrenia treatment and prevention

FV Gomes, AA Grace - International Journal of Molecular Sciences, 2021 - repositorio.usp.br
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat
psychosis, with all of the currently available antipsychotics acting through the antagonism of …

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

FV Gomes, AA Grace - International journal of molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat
psychosis, with all of the currently available antipsychotics acting through the antagonism of …

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

FV Gomes, AA Grace - International Journal of Molecular …, 2021 - search.proquest.com
Abstract Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic
drugs to treat psychosis, with all of the currently available antipsychotics acting through the …

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention.

FV Gomes, AA Grace - International Journal of Molecular Sciences, 2021 - europepmc.org
Abstract Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic
drugs to treat psychosis, with all of the currently available antipsychotics acting through the …
[PDF] researchgate.net

[PDF][PDF] Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

FV Gomes, AA Grace - Int. J. Mol. Sci, 2021 - researchgate.net
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat
psychosis, with all of the currently available antipsychotics acting through the antagonism of …

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention.

FV Gomes, AA Grace, F Iasevoli - International Journal of …, 2021 - search.ebscohost.com
Abstract Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic
drugs to treat psychosis, with all of the currently available antipsychotics acting through the …
[PDF] academia.edu

[PDF][PDF] Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

FV Gomes, AA Grace - Int. J. Mol. Sci, 2021 - academia.edu
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat
psychosis, with all of the currently available antipsychotics acting through the antagonism of …
[PDF] semanticscholar.org

[PDF][PDF] Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

FV Gomes, AA Grace - Int. J. Mol. Sci, 2021 - pdfs.semanticscholar.org
Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat
psychosis, with all of the currently available antipsychotics acting through the antagonism of …